image
Healthcare - Biotechnology - NASDAQ - CA
$ 2.49
-0.797 %
$ 3.01 M
Market Cap
-0.21
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
2011.95%
EBIT Estimate
-0.00%
Net Income Estimate
100.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets InMed Pharmaceuticals Inc.
image
INM has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart INM

image
$100.0m$100.0m$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.02022202220232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart INM

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)($18.0m)($18.0m)($20.0m)($20.0m)2022202220232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart INM

image
$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)($3.0b)($3.0b)($3.5b)($3.5b)2022202220232023202420242025202520262026